Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib maintenance in metastatic colorectal cancer
NCT04296019Phase 2Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Feb 2021
- Primary completion
- Jul 2023
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fruquintinib in colorectal cancer (CRC), sponsored by Zhongshan Hospital, Fudan University. Status: unknown.
02
Drugs
fruquintinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04296019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04296019.